Avenue Biosciences is a series a startup. 1 investor tracked. Status: possibledead.
Avenue Biosciences is a startup founded in 2020 based in Finland. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Avenue Biosciences is dedicated to advancing innovative therapies and diagnostic tools to improve patient outcomes. They focus on research and development in the biotechnology sector.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.